Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
When to stop immunotherapy for advanced melanoma: the emulated target trials.
Amiot M, Mortier L, Dalle S, Dereure O, Dalac S, Dutriaux C, Leccia MT, Maubec E, Arnault JP, Brunet-Possenti F, De Quatrebarbes J, Granel-Brocard F, Gaudy-Marqueste C, Pages C, Stoebner PE, Saiag P, Lesimple T, Dupuy A, Legoupil D, Montaudié H, Oriano B, Lebbe C, Porcher R. Amiot M, et al. Among authors: dalac s. EClinicalMedicine. 2024 Dec 4;78:102960. doi: 10.1016/j.eclinm.2024.102960. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39717261 Free PMC article.
Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM.
Basset-Seguin N, Djermane M, Herms F, Dalac S, Dereure O, Beylot-Barry M, Amini-Adle M, Minart B, Granel-Brocard F, Meyer N, Jouary T, Dreno B, Mortier L; Caraderm investigators. Basset-Seguin N, et al. Among authors: dalac s. J Eur Acad Dermatol Venereol. 2024 Dec 16. doi: 10.1111/jdv.20496. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39676714 No abstract available.
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
Karine B, Mortier L, Dereure O, Dalac S, Montaudié H, Legoupil D, Dutriaux C, De Quatrebarbes J, Maubec E, Leccia MT, Granel-Brocard F, Brunet-Possenti F, Arnault JP, Gaudy-Marqueste C, Pages C, Saiag P, L'orphelin JM, Zehou O, Lesimple T, Allayous C, Porcher R, Oriano B, Dalle S, Lebbé C. Karine B, et al. Among authors: dalac s. Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093/bjd/ljae470. Online ahead of print. Br J Dermatol. 2024. PMID: 39605282
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.
Macaire C, Lefevre W, Dalac S, Montaudié H, Legoupil D, Dereure O, Dutriaux C, Leccia MT, Aubin F, Grob JJ, Saiag P, De Quatrebarbes J, Maubec E, Lesimple T, Granel-Brocard F, Mortier L, Dalle S, Lebbé C, Prod'homme C. Macaire C, et al. Among authors: dalac s. Melanoma Res. 2024 Nov 11. doi: 10.1097/CMR.0000000000000973. Online ahead of print. Melanoma Res. 2024. PMID: 39527777
Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
Bontoux C, Badrignans M, Afach S, Sbidian E, Mboumba DL, Ingen-Housz-Oro S, Claudel A, Aubriot-Lorton MH, Chong-Si-Tsaon A, Le Masson G, Attencourt C, Dubois R, Beltzung F, Koubaa W, Beltraminelli H, Cardot-Leccia N, Balme B, Nguyen AT, Bagny K, Legoupil D, Moustaghfir I, Denamps J, Mortier L, Hammami-Ghorbel H, Skrek S, Rafaa M, Fougerousse AC, Deschamps T, Dalle S, D'incan M, Chaby G, Beylot-Barry M, Dalac S, Ortonne N. Bontoux C, et al. Among authors: dalac s. Br J Dermatol. 2024 Dec 23;192(1):125-134. doi: 10.1093/bjd/ljae312. Br J Dermatol. 2024. PMID: 39133548
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
Zagala R, Dalle S, Beylot-Barry M, Meyer N, Saiag P, Kramkimel N, Lebbe C, Zehou O, Amini-Adle M, Grob JJ, Arnault JP, Maubec E, Granel-Brocard F, Cribier B, Quereux G, Brunet-Possenti F, Dalac S, Dereure O, Drumez E, Mortier L, Battistella M, Jouary T. Zagala R, et al. Among authors: dalac s. J Eur Acad Dermatol Venereol. 2024 Jun 12. doi: 10.1111/jdv.20155. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38864258
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
Rischin D, Hughes BGM, Basset-Séguin N, Schadendorf D, Bowyer S, Trabelsi Messai S, Meier F, Eigentler TK, Casado Echarren V, Stein B, Beylot-Barry M, Dalac S, Dréno B, Migden MR, Hauschild A, Schmults CD, Lim AM, Yoo SY, Paccaly AJ, Papachristos A, Nguyen JH, Okoye E, Seebach F, Booth J, Lowy I, Fury MG, Guminski A. Rischin D, et al. Among authors: dalac s. J Immunother Cancer. 2024 Mar 11;12(3):e008325. doi: 10.1136/jitc-2023-008325. J Immunother Cancer. 2024. PMID: 38471711 Free PMC article. Clinical Trial.
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
Amini-Adle M, Arnault JP, Aubin F, Beneton N, Bens G, Brunet-Possenti F, Célerier P, Charles J, Crumbach L, Dalac S, Darras S, De Quatrebarbes J, Dinulescu M, Dutriaux C, Gaudy C, Gérard E, Giacchero D, Granel-Brocard F, Grange F, Jouary T, Kramkimel N, Lebbé C, Le Corre Y, Legoupil D, Lesage C, Lesimple T, Lorphelin JM, Mansard S, Martin L, Mary-Prey S, Maubec E, Meyer N, Mignard C, Montaudie H, Mortier L, Nardin C, Neidhardt Berard EM, Pagès Laurent C, Peuvrel L, Quereux G, Robert C, Saiag P, Saint-Jean M, Samimi M, Sassolas B, Scalbert C, Skowron F, Steff M, Stoebner PE, Trablesi S, Visseaux L, Zehou O, Boespflug A; GCC group Groupe Cancérologie Cutanée – Cutaneous Oncology Group, the Ethical Group of the Société Française de Dermatologie French Dermatology Group. Amini-Adle M, et al. Among authors: dalac s. Ann Dermatol Venereol. 2024 Mar;151(1):103243. doi: 10.1016/j.annder.2023.103243. Epub 2024 Feb 6. Ann Dermatol Venereol. 2024. PMID: 38325268 No abstract available.
157 results